Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX was delisted on the 23rd of January, 2024.
85 hedge funds and large institutions have $351M invested in Orchard Therapeutics plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 12 closing their positions.
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
2% more funds holding
Funds holding: 83 → 85 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 28
36% less capital invested
Capital invested by funds: $546M → $351M (-$195M)
97% less call options, than puts
Call options by funds: $37K | Put options by funds: $1.24M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$15.6M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$2.55M |
| 3 |
JP Morgan Chase
New York
|
+$1.14M |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$885K |
| 5 |
BlackRock
New York
|
+$826K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ABG
Ally Bridge Group
New York
|
-$3.97M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$2.99M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$2.01M |
| 4 |
Millennium Management
New York
|
-$1.57M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$1.25M |
ORTX Hedge Fund Activity: Q2 2021 in Review
85 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q2 2021, worth a combined $351M — down 36% from $546M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ORTX positions and 12 closed out — a net gain of 2 holders — while 23 added to existing stakes and 28 trimmed.
The largest buyer was Artisan Partners, adding an estimated $15.6M. The largest seller was Ally Bridge Group, exiting entirely with an estimated $3.97M sold.
- 85 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q2 2021, up from 83 in Q1 2021.
- Funds reported $351M of Orchard Therapeutics plc American Depositary Shares stock for Q2 2021, down 36% quarter-over-quarter.
- 14 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q2 2021 and 12 closed out, a net change of +2 holders.
- The largest Orchard Therapeutics plc American Depositary Shares buyer in Q2 2021 was Artisan Partners, an estimated $15.6M added.
- The largest Orchard Therapeutics plc American Depositary Shares seller in Q2 2021 was Ally Bridge Group, an estimated $3.97M sold.
Based on aggregated 13F filings for Q2 2021.